BEACHWOOD, Ohio — Trailhead Biosystems Inc. (TrailBio.com), a biotechnology company pioneering the creation of iPSC-derived human cells at scale for drug discovery and cell therapy, is pleased to announce the appointment of David Llewellyn, PhD, MBA as its new Chief Executive Officer, and as a member of its Board of Directors. Dr. Llewellyn succeeds Jan Jensen, PhD, who […]
HAMBURG, Germany — n6, the award-winning innovator in next-generation sequencing (NGS) workflow solutions, is proud to announce a major expansion of its European enablement efforts. Building on the momentum of winning the “Best New Product” award at SLAS earlier this year, n6 is deepening its commitment to supporting scientists across Europe by simplifying complex workflows and bringing […]
The partnership aims to provide game-changing luminescent lanthanide-based oligo probes for diagnostics and life science research applications. Morrisville, NC / Berkeley, CA — SynOligo Biotechnologies Inc. and Lumiphore Inc. announced they have entered into a partnership to incorporate Lumiphore’s luminescent lanthanide reporter technology conjugated to SynOligo’s oligonucleotide offerings for diagnostic tests and use in life […]
FOSTER CITY, Calif. — Signios Biosciences (“Signios Bio”), a science-first biotechnology company leading in multiomics and AI-powered bioinformatics, in collaboration with Illumina, announced today an Illumina-sponsored grant for Early Access to Illumina Protein Prep 9.5K™. Powered by SOMAmer® technology, this next-generation sequencing (NGS)-based platform enables comprehensive proteomic profiling of plasma and serum. Illumina Protein Prep 9.5K™ utilizes slow […]
Appoints new CEO and VP of Commercial to drive commercial expansion and portfolio strategy HOLLISTON, Mass. – Oligo Factory, a leading science-driven provider of high-quality custom DNA and RNA oligonucleotides for therapeutic, diagnostic, and life science applications, today announced the launch of its new low-scale oligo synthesis capability. This expansion enhances the company’s ability to broaden […]
Introducing Cheetah™ FLEX and Cheetah™ PEA-PLEX HotStart Taq DNA Polymerases for qPCR, PEA, and NGS-Based PEA Workflows FREMONT, CA — Biotium, a leading provider of fluorescent reagents for life science research, proudly expands its trusted Cheetah™ Taq DNA Polymerase line with two new formulations: Cheetah™ FLEX HotStart Taq DNA Polymerase and Cheetah™ PEA-PLEX HotStart Taq DNA Polymerase. These optimized […]
Morpho Biotech announces it has signed a distribution agreement with MACHEREY-NAGEL (MN) to distribute their Bioanalysis portfolio in the Netherlands as of July 1st. MN is an innovative international company for chemical and biomolecular analysis. The Bioanalysis portfolio of MN consists of efficient and reliable kits for RNA, DNA and protein purification from various sample […]
Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies that may improve patient outcomes SEOUL, South Korea — Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Ubix Therapeutics to accelerate highly targeted cancer therapy research and development in South Korea over […]
First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research Fremont, California. Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAseq™ CNS Disease Panel 120 to include novel assays for brain-derived phosphorylated tau (pTau) proteins. The enhanced panel now […]
N of 1 therapy uniquely developed, on demand, for infant with life-threatening rare metabolic disorder in six months Results published in The New England Journal of Medicine and showcased at American Society of Gene & Cell Therapy Annual Meeting Fargo, ND and Coralville, IA — Aldevron, a global leader in the production of DNA, RNA […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
